Christopher Goetz to Pyridines
This is a "connection" page, showing publications Christopher Goetz has written about Pyridines.
Connection Strength
0.190
-
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. Mov Disord. 2016 09; 31(9):1373-80.
Score: 0.141
-
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. Arch Neurol. 2001 Feb; 58(2):249-54.
Score: 0.049